Vitórya Carvalho Pádua de Magalhães
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vitórya Carvalho Pádua de Magalhães has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Sheila Cavalca Cortelli
Faculdade São Leopoldo Mandic, Campinas, SP, Brasil
3 shared publications - José Roberto Cortelli
University of Taubate
2 shared publications - Rodrigo Augusto da Silva
Health Science Post‐Graduate Program University of Taubaté – UNITAU Taubaté Brazil
2 shared publications - Bruna Hentges
Universidade Federal do Rio Grande do Sul, Brazil
1 shared publication - Camila Lopes Ferreira
Health Science Post‐Graduate Program University of Taubaté – UNITAU Taubaté Brazil
1 shared publication Davi Romeiro Aquino
University of Taubate
1 shared publication
Latest Publications
- Open Access
- 9 October 2026
- Published by Wiley in Analytical Science Advances
- Vol. 7 (2)
Predicting the Risk of Proteinuria Based on Blood Plasma Fourier‐Transform Infrared Spectroscopy and Machine Learning Algorithms From Pregnant Women and Newborns
Proteinuria, defined by an abnormally elevated concentration of proteins in the urine, serves as a critical biomarker for the early detection and diagnosis of preeclampsia. Elevated proteinuria levels adversely affect both maternal and foetal health, increasing the risk of preterm birth and low birth weight. This study focused on the identification of proteinuria in blood samples through Fourier‐transform infrared (FTIR) spectroscopy as a diagnostic tool for real‐time diagnosis. Blood plasma collected during birth was evaluated in four study groups: pregnant controls ( n = 12), pregnant women with proteinuria ( n = 13), newborn controls ( n = 12), newborns with proteinuria ( n = 14). First, attenuated total reflectance‐FTIR spectra of plasma samples were collected for subsequent spectral smoothing, vector normalisation and machine‐learning classification with various supervised machine learning algorithms, including several types of Support Vector Machine, K‐Nearest Neighbours and decision trees. We obtained (76.1 ± 3.1)% accuracy, (72.1 ± 4.8)% sensitivity and (80.4 ± 3.8)% specificity for pregnant classification, and (90.6 ± 1.5)% accuracy, (83.3 ± 2.4)% sensitivity and (98.9 ± 1.6)% specificity for newborn classification. The vibrational modes corresponding to the predominant biochemical components in blood plasma of pregnant women and newborns were listed. Sensitivity and specificity results demonstrated that FTIR can be a promising tool for early diagnosis and monitoring of individual proteinuria. Although the proposed spectroscopic approach demonstrated promising diagnostic performance, the findings should be interpreted in light of clinical conditions that could affect the biochemical profile. Further studies involving larger and more heterogeneous populations are required to validate the proposed methodology.
- 9 October 2026
- Published by Wiley in Analytical Science Advances
- Vol. 7 (2)
Open AccessPredicting the Risk of Proteinuria Based on Blood Plasma Fourier‐Transform Infrared Spectroscopy and Machine Learning Algorithms From Pregnant Women and Newborns
Proteinuria, defined by an abnormally elevated concentration of proteins in the urine, serves as a critical biomarker for the early detection and diagnosis of preeclampsia. Elevated proteinuria levels adversely affect both maternal and foetal health, increasing the risk of preterm birth and low birth weight. This study focused on the identification of proteinuria in blood samples through Fourier‐transform infrared (FTIR) spectroscopy as a diagnostic tool for real‐time diagnosis. Blood plasma collected during birth was evaluated in four study groups: pregnant controls ( n = 12), pregnant women with proteinuria ( n = 13), newborn controls ( n = 12), newborns with proteinuria ( n = 14). First, attenuated total reflectance‐FTIR spectra of plasma samples were collected for subsequent spectral smoothing, vector normalisation and machine‐learning classification with various supervised machine learning algorithms, including several types of Support Vector Machine, K‐Nearest Neighbours and decision trees. We obtained (76.1 ± 3.1)% accuracy, (72.1 ± 4.8)% sensitivity and (80.4 ± 3.8)% specificity for pregnant classification, and (90.6 ± 1.5)% accuracy, (83.3 ± 2.4)% sensitivity and (98.9 ± 1.6)% specificity for newborn classification. The vibrational modes corresponding to the predominant biochemical components in blood plasma of pregnant women and newborns were listed. Sensitivity and specificity results demonstrated that FTIR can be a promising tool for early diagnosis and monitoring of individual proteinuria. Although the proposed spectroscopic approach demonstrated promising diagnostic performance, the findings should be interpreted in light of clinical conditions that could affect the biochemical profile. Further studies involving larger and more heterogeneous populations are required to validate the proposed methodology.
- Open Access
- 18 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357206
Salivary and serum levels of NT-proBNP, troponin, and high-sensitivity C-reactive protein in patients with heart failure
Background: Saliva has been proposed as a non-invasive biological matrix for cardiovascular biomarker assessment. However, evidence regarding its agreement with blood-based measurements in patients with heart failure remains inconsistent. Objective: To assess the presence of NT-proBNP, troponin, and high-sensitivity C-reactive protein in saliva and their correlation with serum concentrations in patients with heart failure over a six-month follow-up period. Methods: Participants were prospectively evaluated, and paired saliva and blood samples were collected at baseline, 3 and 6 months. The population included 52 individuals (30 males and 22 females) with HFmrEF (LVEF 41–49%) or HFrEF (LVEF ≤40%), aged 49–80 years (mean age of 61.1 ± 6.79 years). Biomarker concentrations were measured in both matrices. Agreement between salivary and serum measurements was assessed using Bland–Altman analysis. Additional analyses explored whether age influenced the relationship between salivary and serum biomarker levels. Results: All three biomarkers were consistently detectable in whole saliva. However, Bland–Altman analyses showed that salivary NT-proBNP and troponin did not demonstrate clinically acceptable agreement with serum concentrations at any evaluated time point, indicating limited interchangeability between matrices. In contrast, hs-CRP exhibited relatively better agreement between saliva and serum, with mean bias close to zero and moderate limits of agreement, although substantial inter-individual variability persisted. Age and sex did not meaningfully influence the relationship between salivary and serum biomarker concentrations. Conclusions: Although NT-proBNP, troponin, and hs-CRP are detectable in saliva, salivary measurements of NT-proBNP and troponin showed insufficient agreement with serum levels to support their use as substitutes for blood-based assessment in heart failure. hs-CRP demonstrated comparatively better performance but remains limited by variability. Under the conditions evaluated, serum remains the reference standard for cardiovascular biomarker assessment in heart failure, and saliva should be regarded as a matrix warranting further investigation.
- 18 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357206
Open AccessSalivary and serum levels of NT-proBNP, troponin, and high-sensitivity C-reactive protein in patients with heart failure
Background: Saliva has been proposed as a non-invasive biological matrix for cardiovascular biomarker assessment. However, evidence regarding its agreement with blood-based measurements in patients with heart failure remains inconsistent. Objective: To assess the presence of NT-proBNP, troponin, and high-sensitivity C-reactive protein in saliva and their correlation with serum concentrations in patients with heart failure over a six-month follow-up period. Methods: Participants were prospectively evaluated, and paired saliva and blood samples were collected at baseline, 3 and 6 months. The population included 52 individuals (30 males and 22 females) with HFmrEF (LVEF 41–49%) or HFrEF (LVEF ≤40%), aged 49–80 years (mean age of 61.1 ± 6.79 years). Biomarker concentrations were measured in both matrices. Agreement between salivary and serum measurements was assessed using Bland–Altman analysis. Additional analyses explored whether age influenced the relationship between salivary and serum biomarker levels. Results: All three biomarkers were consistently detectable in whole saliva. However, Bland–Altman analyses showed that salivary NT-proBNP and troponin did not demonstrate clinically acceptable agreement with serum concentrations at any evaluated time point, indicating limited interchangeability between matrices. In contrast, hs-CRP exhibited relatively better agreement between saliva and serum, with mean bias close to zero and moderate limits of agreement, although substantial inter-individual variability persisted. Age and sex did not meaningfully influence the relationship between salivary and serum biomarker concentrations. Conclusions: Although NT-proBNP, troponin, and hs-CRP are detectable in saliva, salivary measurements of NT-proBNP and troponin showed insufficient agreement with serum levels to support their use as substitutes for blood-based assessment in heart failure. hs-CRP demonstrated comparatively better performance but remains limited by variability. Under the conditions evaluated, serum remains the reference standard for cardiovascular biomarker assessment in heart failure, and saliva should be regarded as a matrix warranting further investigation.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Pesquisa Brasileira em Odontopediatria e Clínica Integrada
- Vol. 26
Inhalation of Lavender Essential Oil for the Management of Anxiety and Pain During Dental Procedures: A Randomized Controlled Trial
Objective: To evaluate the lavender essential oil effects on pain and anxiety in dental patients. Material and Methods: Forty patients, aged 18-60 years, undergoing dental procedures were randomly assigned to lavender essential oil (experimental group; n=20) or negative control (n = 20). In the essential oil group, participants inhaled pure lavender essential oil under supervision 5 times, 15 minutes before the dental procedure, directly from the bottle held at a distance of 15 cm. In the negative control group, participants inhaled five times, under supervision, a hydroalcoholic solution directly from the bottle held at a distance of 15 cm, 15 minutes before the dental procedure. Pain was assessed with the Visual Analog Scale (VAS) and anxiety with the Dental Anxiety Scale (DAS). Results: Baseline anxiety ranged from mild (6-10) to moderate (11-15), with no spontaneous pain (score 0). Both groups reported mild treatment-related pain (VAS: 1.2 experimental vs 1.7 control; p > 0.05). The experimental group showed significantly greater anxiety reduction post-treatment (p < 0.05). Conclusion: Lavender inhalation positively modulates pain perception and significantly reduces anxiety, suggesting a cost-effective adjunct in routine dental practice.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Pesquisa Brasileira em Odontopediatria e Clínica Integrada
- Vol. 26
Open AccessInhalation of Lavender Essential Oil for the Management of Anxiety and Pain During Dental Procedures: A Randomized Controlled Trial
Objective: To evaluate the lavender essential oil effects on pain and anxiety in dental patients. Material and Methods: Forty patients, aged 18-60 years, undergoing dental procedures were randomly assigned to lavender essential oil (experimental group; n=20) or negative control (n = 20). In the essential oil group, participants inhaled pure lavender essential oil under supervision 5 times, 15 minutes before the dental procedure, directly from the bottle held at a distance of 15 cm. In the negative control group, participants inhaled five times, under supervision, a hydroalcoholic solution directly from the bottle held at a distance of 15 cm, 15 minutes before the dental procedure. Pain was assessed with the Visual Analog Scale (VAS) and anxiety with the Dental Anxiety Scale (DAS). Results: Baseline anxiety ranged from mild (6-10) to moderate (11-15), with no spontaneous pain (score 0). Both groups reported mild treatment-related pain (VAS: 1.2 experimental vs 1.7 control; p > 0.05). The experimental group showed significantly greater anxiety reduction post-treatment (p < 0.05). Conclusion: Lavender inhalation positively modulates pain perception and significantly reduces anxiety, suggesting a cost-effective adjunct in routine dental practice.